Health Care & Life Sciences » Biotechnology | Elanix Biotechnologies AG

Elanix Biotechnologies AG

Elanix Biotechnologies AG
Stock Exchange Frankfurt Stock Exchange
EPS
EUR0.58
Market Cap
EUR22.48 M
Shares Outstanding
7.78 M
Public Float
-

Profile

Address
Hohenstaufenstrasse 1
Wiesbaden Hessen 65189
Germany
Employees -
Website http://www.elanix-biotechnologies.de
Updated 07/08/2019
Elanix Biotechnologies AG operates as a holding company, which engages in the development and marketing of progenitor cell-based products for acute wound care, as well as dermatological and gynecological applications. It operates through the Regenerative Medicine and Cosmetic Ointments business segments. The Regenerative Medicine segment offers skin dressings made from progenitor skin fibroblasts to provide protection and accelerated healing for burns and reconstructive surgery.

Financials

View All

J├╝rgen Ferdinand Kullmann
Chairman-Supervisory Board
Marc Voigt
Vice Chairman-Supervisory Board